BRIEF-Hims & Hers Expands Personalized Weight Loss Portfolio With Access To Compounded Semaglutide Pills Starting At $49/Month*

Reuters
Feb 05
BRIEF-Hims & Hers Expands Personalized Weight Loss Portfolio With Access To Compounded Semaglutide Pills Starting At $49/Month*

Feb 5 (Reuters) - Hims & Hers Health Inc HIMS.N:

  • HIMS & HERS EXPANDS PERSONALIZED WEIGHT LOSS PORTFOLIO WITH ACCESS TO COMPOUNDED SEMAGLUTIDE PILLS STARTING AT $49/MONTH*

  • HIMS & HERS HEALTH INC: THIS COMPOUNDED PRODUCT USES A DIFFERENT FORMULATION AND DELIVERY SYSTEM THAN FDA-APPROVED ORAL SEMAGLUTIDE

Source text: ID:nBw4YMZjNa

Further company coverage: HIMS.N

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10